Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The licensed indications include adults with a body mass index (BMI) of 30 kg/m or above with weight-related comorbidities
Around the same time, off-label use of Mounjaro (use among people without T2D) sharply decreased, corresponding with both the end of the Wegovy shortage and the first report of Mounjaro shortages (which have now ended)
The vial is manufactured under controlled conditions and tested for purity to support consistent, reliable results in research settings
FDA Label Novo Nordisk
US$ 25.69
US$ 20.55
US$ 28.24
US$ 28.35
US$ 27.23
US$ 20.44
